Pharmacist-driven outreach initiative to increase prescribing of sodium-glucose cotransporter-2 inhibitors in eligible VHA patients with chronic kidney disease: a study protocol

Pharmacist-driven outreach initiative to increase prescribing of sodium-glucose cotransporter-2 inhibitors in eligible VHA patients with chronic kidney disease: a study protocol

Abstract Background Patients with chronic kidney disease (CKD) are at increased risk for multiple adverse events, several of which have been proven to be less likely with the use of sodium-glucose cotransporter-2 inhibitors (SGLT2i). As a result, guidelines now recommend SGLT2i be given to those wit...

Full description

Bibliographic Details
Main Authors: Deborah L. Pestka, Daniel Murphy, Pearl Huynh, Jessica A. Rechtzigel, Shari Kjos, Lisa Marie Ellich, Adam N. Kaplan, Brent C. Taylor, Melissa Atwood, Beth A. Polsfuss, Joseph Y. Lee, Areef Ishani
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Nephrology
Subjects:
Chronic Kidney Disease
Implementation strategy
Clinical pharmacy services
Online Access:https://doi.org/10.1186/s12882-023-03446-1

Internet

https://doi.org/10.1186/s12882-023-03446-1

Similar Items